FRS2-LACRT Fusion FISH Probe
The FRS2-LACRT Fusion FISH Probe is used to confirm a fusion of the FRS2 and LACRT genes. The fusion of the FRS2 and LACRT genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| FRS2-LACRT-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-RERE | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-REOR | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-REGO | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-REGR | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-OROR | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-GORE | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-GROR | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| FRS2-LACRT-20-AQAQ | 20 (40 μL) | 200 μL |
|
FRS2 Gene Summary
The Fibroblast Growth Factor Receptor Substrate 2 (FRS2) gene is located on chr12 :69864128-69973562 at 12q15.
Gene Name: Fibroblast Growth Factor Receptor Substrate 2
Chromosome: CHR12: 69864128 -69973562
Locus: 12q15
LACRT Gene Summary
The protein encoded by this gene is highly expressed in the lacrimal glands and localized primarily to secretory granules and secretory fluid. It augments lacrimal acinar cell secretion, promotes ductal cell proliferation, and stimulates signaling through tyrosine phosphorylation and release of calcium. [provided by RefSeq, Jul 2008]
Gene Name: Lacritin
Chromosome: CHR12: 55024622 -55028663
Locus: 12q13.2
Gene Diseases
The FRS2 LACRT Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|